Cervical Cancer

Related Links

Find a patient education handout on this topic.

The AAFP recommends screening for cervical cancer in women age 21 to 65 years with cytology (Pap smear) every 3 years or, for women age 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years. (2012)

(Grade: A recommendations)
(Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm#arec(www.uspreventiveservicestaskforce.org))
(Clinical Considerations: http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs.htm#clinical(www.uspreventiveservicestaskforce.org))

The AAFP recommends against screening for cervical cancer in women younger than age 21 years. (2012)

(Grade: D recommendation)
(Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm#arec(www.uspreventiveservicestaskforce.org))
(Clinical Considerations: http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs.htm#clinical(www.uspreventiveservicestaskforce.org))

The AAFP recommends against screening for cervical cancer in women older than age 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer. See the Clinical Considerations for discussion of adequacy of prior screening and risk factors. (2012)

(Grade: D recommendation)
(Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm#arec (www.uspreventiveservicestaskforce.org)
(Clinical Considerations: http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs.htm#clinical(www.uspreventiveservicestaskforce.org))

The AAFP recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade precancerous lesion (cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer. (2012)

(Grade: D recommendation)
(Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm#arec(www.uspreventiveservicestaskforce.org))
(Clinical Considerations: http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs.htm#clinical(www.uspreventiveservicestaskforce.org))

The AAFP recommends against screening for cervical cancer with HPV testing, alone or in combination with cytology, in women younger than age 30 years. (2012)

(Grade: D recommendation)
Grade Definition: http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm#arec (www.uspreventiveservicestaskforce.org)
Clinical Considerations: http://www.uspreventiveservicestaskforce.org/uspstf11/cervcancer/cervcancerrs.htm#clinical(www.uspreventiveservicestaskforce.org))